Courses

This CME/CE program is derived from content presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). The expert faculty, led by Fred D. Lublin, MD, will highlight the important emerging role of Bruton's tyrosine kinase (BTK) inhibitors as the first brain penetrant disease modifying therapy that offers opportunities to improve neuroinflammation and neurodegeneration. The faculty ...
View Course

This CME program is derived from content presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Conference. Long-term protection from thrombotic/ischemic complications in patients with chronic coronary disease is an increasingly important topic given the aging of the population and the improved survival rates after an acute coronary syndrome (ACS). There are emerging data that support both dual antiplatelet therapy (DAPT) ...
View Course

This CME/CNE activity will highlight updates in secondary prevention of ischemic stroke and transient ischemic attack. The expert faculty, Dr. Stephan Mayer, will first delve into the pathophysiology and disease burden of early recurrent ischemic neurovascular events. Next, Dr. Mayer will review the importance of antiplatelet therapy with both ASA and P2Y₁₂ inhibitors in acute and early secondary prevention. Following, ...
View Course

This CME program is derived from content presented at the Eastern Pulmonary Conference Annual Meeting. The expert faculty, Dr. Anne E. O’Donnell, will first highlight the pathophysiology, prevalence, and high-risk subgroups of non-tuberculous mycobacterial lung disease (NTM-LD). Following, Dr. O’Donnell will analyze current strategies for determining immunocompetent hosts and detecting radiographic manifestations in NTM-LD. The clinical implications of recent trial ...
View Course

This CME/CE program is derived from content presented as part of a larger rheumatology state meeting lecture series. The expert faculty, Dr. Dinesh Khanna, will first discuss the history of systemic sclerosis-associated interstitial lung disease, including prevalence, predictors of progressive ILD and screening. Following, recent clinical trial data in the interstitial lung disease treatment landscape will be reviewed, encompassing both ...
View Course

This CME/CE webcast, chaired by Fred D. Lublin, MD, will analyze current best practices for utilizing fumarate-based therapeutics to improve outcomes in patients with multiple sclerosis (MS). The expert faculty will first review the mechanism of action and targets of fumarates in the MS treatment landscape. Following, current trial data of fumarate-based therapeutics in MS will be reviewed and clinical ...
View Course

This CME activity is derived from content presented at the 7^th Annual European Stroke Organization Conference (ESOC) 2021 Virtual. The expert faculty, led by Dr. Stephan Mayer, will first provide an overview of double antiplatelet therapy, including pathobiology, disease mechanisms and platelet activation. Following, clinical trial data in stroke and cardiovascular disease will be reviewed. Next, the pros and cons ...
View Course

This CME/CE symposium is derived from content presented at the Congress of Clinical Rheumatology East Meeting and will highlight recent advances in the treatment and management of patients with interstitial lung disease (ILD). The expert faculty, Drs. Dinesh Khanna and Kevin Flaherty, will first review best practices for screening and diagnosing patients. Following, recent clinical trial data of both emerging ...
View Course

In this module, Jamie Faber, PA-C, along with Scott Kopetz, MD, PhD, course chair, will first delve into the practical considerations of biomarker testing for the interprofessional team. The expert faculty will also provide an overview of ctDNA, including the clinical implications in the colorectal cancer landscape. Following, best practices for managing adverse events to improve patient outcomes will be ...
View Course

In this module, Michael Sangmin Lee, MD, along with Scott Kopetz, MD, PhD, course chair, will review data presented at the ESMO World Congress on Gastrointestinal Cancer 2021 Meeting. The faculty will outline a few key studies from the meeting, focusing on populations such as those who were previously untreated and patients who received prior bevacizumab treatment. Current topics such ...
View Course